Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rehabilicare was a medical device company that specialized in the development and commercialization of non-invasive electrotherapy products for pain management and physical rehabilitation. The company's core product lines included transcutaneous electrical nerve stimulation (TENS) and neuromuscular electrical stimulation (NMES) devices, which were primarily marketed to orthopedic surgeons and physical therapists. Originally founded as Staodyn, the company rebranded to Rehabilicare in 1998 to reflect its broader focus on the rehabilitation market. In 2003, Rehabilicare merged with Compex Technologies in a deal valued at approximately $100 million, and its technologies were eventually integrated into DJO Global following subsequent acquisitions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rehabilicare.